Phenoxybenzamine-d5
Modify Date: 2024-07-29 19:26:41
Phenoxybenzamine-d5 structure
|
Common Name | Phenoxybenzamine-d5 | ||
|---|---|---|---|---|
| CAS Number | 1309283-11-1 | Molecular Weight | 308.86 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C18H17D5ClNO | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Phenoxybenzamine-d5Phenoxybenzamine-d5 is the deuterium labeled Phenoxybenzamine[1]. Phenoxybenzamine is a nonselective, irreversible, orally active α-adrenoceptor antagonist that is commonly used for the research of hypertension, specifically caused by pheochromocytoma. Phenoxybenzamine also shows antitumor activity[2][3]. |
| Name | Phenoxybenzamine-d5 |
|---|
| Description | Phenoxybenzamine-d5 is the deuterium labeled Phenoxybenzamine[1]. Phenoxybenzamine is a nonselective, irreversible, orally active α-adrenoceptor antagonist that is commonly used for the research of hypertension, specifically caused by pheochromocytoma. Phenoxybenzamine also shows antitumor activity[2][3]. |
|---|---|
| Related Catalog | |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
| References |
| Molecular Formula | C18H17D5ClNO |
|---|---|
| Molecular Weight | 308.86 |